Cargando…
Anticoagulation in COVID-19
Autores principales: | Atallah, Bassam, Mallah, Saad I, AlMahmeed, Wael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197600/ https://www.ncbi.nlm.nih.gov/pubmed/32352517 http://dx.doi.org/10.1093/ehjcvp/pvaa036 |
Ejemplares similares
-
Adapting to the COVID-19 Pandemic at a Quaternary Care Hospital in the Middle East Gulf Region
por: Atallah, Bassam, et al.
Publicado: (2020) -
Lipid Control Post Coronary Artery Bypass Graft: One Year Follow-Up of a Middle-Eastern Cohort
por: Atallah, Bassam, et al.
Publicado: (2020) -
Traveling for heart transplantation and returning with COVID-19: a logistical, clinical, and pharmacotherapeutic challenge from the Middle East
por: Atallah, Bassam, et al.
Publicado: (2020) -
The role of renin-angiotensin system activated phagocytes in the SARS-CoV-2 coronavirus infection
por: Göbölös, Laszlo, et al.
Publicado: (2021) -
Thrombotic events following tocilizumab therapy in critically ill COVID-19 patients: a Façade for prognostic markers
por: Atallah, Bassam, et al.
Publicado: (2020)